Nference

Nference Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series B1
  • Latest Deal Amount
  • $9.6M
Latest Deal Amount
  • Investors
  • 4

Nference General Information

Description

Developer of a holistic software platform intended to synthesize the exponentially growing biomedical knowledge. The company's platform utilises neural networks for real-time, automated extraction of insights by triangulating unstructured and structured information from the biomedical literature as well as from large scale molecular and real-world datasets, enabling healthcare enterprises to make biomedical knowledge computable.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Other Healthcare Technology Systems
Primary Office
  • One Main Street, Suite 400
  • East Arcade, 4th Floor
  • Cambridge, MA 02142
  • United States
+1 (781) 000-0000

Nference Timeline

2017201820192020
Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nference Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B1) 12-Mar-2020 $9.6M 000.00 00000 Completed Generating Revenue
4. Later Stage VC (Series B) 08-Jan-2020 0000 0000 00000 Completed Generating Revenue
3. Early Stage VC (Series A1) 31-Aug-2018 000 0000 00000 Completed Generating Revenue
2. Early Stage VC (Series A) 06-Jun-2018 $11M $14M 000.00 Completed Generating Revenue
1. Seed Round 30-Jun-2017 $3M $3M 000 Completed Generating Revenue

Nference Cap Table

To view Nference‘s complete cap table, request access »
Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-1 000,000 00.000000 000.00 000.00 00 000.00 0.000
Series B 0,000,000 00.000000 00.00 00.00 00 00.00 00.00
Series A-1 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A 3,105,591 $0.001000 $3.54 $3.54 1x $3.54 6.89%
Seed 6,635,687 $0.001000 $0.48 $0.48 1x $0.48 14.73%

Nference Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
BenevolentAI Private Equity-Backed London, United Kingdom 000 00000 0000000 0000 00000
0000000 Corporation Branford, CT
00000 Venture Capital-Backed Campbell, CA 000 000.00 0000000000 0 000.00
00000000 Venture Capital-Backed Mountain View, CA 000 00000 00000000000 00000
0000000000000 Private Equity-Backed Richardson, TX 000 0000 000000000000 0000

Nference Executive Team (14)

Name Title Board Seat Contact Info
Murali Aravamudan Co-Founder, Chief Executive Officer & Board Member
Ajit Rajasekharan Chief Technology Officer
Venky Soundararajan Ph.D Co-Founder & Chief Scientific Officer
Agustin Marquez Vice President, Marketing and Business Development
Paul Clemons Ph.D Advisory Board Member

Nference Board Members (4)

Name Representing Role Since
Andrew Danielsen Mayo Clinic Board Member 000 0000
David Goel Matrix Capital Management Board Member 000 0000
Murali Aravamudan Nference Co-Founder, Chief Executive Officer & Board Member 000 0000
Tim Barrows Self Board Member 000 0000

Nference Investors (4)

To view Nference‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Mayo Clinic VC-Backed Company Minority 000 0000 000000 0
NTT Venture Capital Venture Capital Minority 000 0000 000000 0
Matrix Partners Venture Capital Minority 000 0000 000000 0
Matrix Capital Management Hedge Fund Minority 000 0000 000000 0

Nference Investments (1)

To view Nference‘s complete investment and acquisition history, request access »
Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 14-Jul-2017 00000 0000000 Drug Discovery

Ready to get started?

Request a free trial